Aridis Pharmaceuticals Stock News

The stock price of Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) increased by over 30% during intraday trading today. This is why it happened.

Gainers: Exterran EXTN +51%.Aridis Pharmaceuticals (ARDS) +36%.Kohl''s KSS +31%.ShiftPixy PIXY +31%.G Medical Innovations GMVD +14%.Hall of Fame (HOFV) +14%.Shineco SISI +12%.Atlas…

Thanks to continued fear and uncertainty, the stock market is down again… The post 4 Penny Stocks Up Big With The Stock Market Down Today; Time To Buy? appeared first on Penny Stocks to Buy, Picks,

Are these penny stocks on your watchlist for next week? The post Can These Penny Stocks Climb This Week?

Aridis Pharmaceuticals Inc (ARDS) shares closed this week 26.9% lower than it did at the end of last week. The stock is currently down 28.1% year-to-date, down 73.2% over the past 12 months, and down 87.1% over the past five years. This week, the Dow Jones Industrial Average fell 1.3%, and the S&P 500 fell 2.6%. Trading Activity Shares traded as high as $2.32 and as low as $1.56 this week.Trading volume this week was 11.4% lower than the 10-day average and 83.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1434.7% The company's stock price performance over the past 12 months lags the peer average by 710.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Aridis Pharmaceuticals Inc (ARDS) shares closed today 11.8% lower than it did at the end of yesterday. The stock is currently down 26.2% year-to-date, down 71.3% over the past 12 months, and down 86.8% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $2.42 and as low as $1.69 this week.Shares closed 79.7% below its 52-week high and 1.8% above its 52-week low.Trading volume this week was 59.3% lower than the 10-day average and 84.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 9946.0% The company's stock price performance over the past 12 months lags the peer average by 715.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Aridis Pharmaceuticals Inc (ARDS) shares closed today at 1.8% above its 52 week low of $1.69, giving the company a market cap of $24M. The stock is currently down 26.2% year-to-date, down 71.3% over the past 12 months, and down 86.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 84.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 9946.0% The company's stock price performance over the past 12 months lags the peer average by 715.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

These penny stocks climbed during premarket trading today, here's why The post 3 Penny Stocks That Exploded in Premarket Trading Today appeared first on Penny Stocks to Buy, Picks, News and Informatio

If you're making a penny stocks watchlist right now, check these three out The post Are These Top Penny Stocks Worth Buying Right Now? appeared first on Penny Stocks to Buy, Picks, News and Informatio

Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) traded at $2.78 at close of the session on Tuesday, 12/21/21, made an upward move of 9.45% on its previous days price. Looking at the stock we see that its previous close was $2.54 and the beta (5Y monthly) reads 0.11 with the days price range being $2.64 $4.34. In Investors Take Advantage Of 9.45% Gain In Aridis Pharmaceuticals Inc. (NASDAQ: ARDS) Read More »

Gainers Reliance Global Group, Inc. (NASDAQ: RELI ) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI ) climbed 71.4% to $13.06 after gaining over 7% on Monday. Biofrontera recently announced the first subject has been enrolled in the Phase 2b study to evaluate the safety and efficacy of Ameluz in combination with the red-light lamp BF-RhodoLED for acne. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS ) jumped 36% to $3.4550 after the company reported pan-coronavirus monoclonal antibody cocktail that retains effectiveness against the omicron variant, other covid-19 variants, SARS, MERS, and the common cold human coronaviruses. Petros Pharmaceuticals, Inc. (NASDAQ: PTPI ) shares climbed 33.8% to $4.55. Evofem Biosciences, Inc. (NASDAQ: EVFM ) rose 24.1% to $0.46. The companys CEO Saundra L Pelletier bought 135,000 shares at an average price of $0.38 per share. Quantum-Si incorporated (NASDAQ: QSI ) gained 23.7% to $7.83. IsoPlexis Corporation (NASDAQ: ISO ) jumped 22.2% to $5.99.

Aridis Pharmaceuticals has a new cocktail, and it may be the ticket out of the omicron variant. Here''s why ARDS stock is worth watching.

Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) has a beta value of 0.18 and has seen 23.19 million shares traded in the recent trading session. The company, currently valued at $33.05M, closed the recent trade at $3.20 per share which meant it gained $0.66 on the day or 25.98% during that session. The ARDS stock price is -164.69% Shares In Aridis Pharmaceuticals Inc. (ARDS) -58.15% Down, YTD Read More »

NEW YORK , Dec. 21, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for QNRX, ARDS, BFRI, SAVA, and ERJ. Full story available on Benzinga.com